fbpx
Medical Innovation Exchange

Bristol Myers on track for third new drug launch of 2022 with latest deucravacitinib data

https://www.fiercebiotech.com/biotech/bms-new-safety-data-psoriasis-drug-puts-company-track-third-new-drug-launch-2022

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.